A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization

The optimal management of asymptomatic overanticoagulated patients remains unknown. Mie measured international normalized ratio (INR), activated partial thromboplastin time (APTT) and prothrombin fragment 1 + 2 (F1 + 2) over 7 d in 24 asymptomatic or mildly haemorrhagic patients on warfarin with prolonged INR of > 7.0 who were randomized to receive 0.5 mg, 1 mg or 2 mg intravenous vitamin It. Of six severely overanticoagulated patients (INR > 9.5 with APTT ratio > 2), five failed to achieve an INR less than or equal to 4.0 on day 1, irrespective of vitamin IC dose given, In the remaining 18 cases, an optimal response (INR 2-4 at day 1) was observed in 67% of those receiving 0.5 mg vitamin K, but only in 33% of those receiving 1 or 2 mg, the majority of whom developed an INR < 2.0. Our results support an optimal dose of 0.5 mg i.v. Vitamin It for most overanticoagulated patients, with possibly a repeat dose in the small group of severely overanticoagulated patients.